The largest database of trusted experimental protocols

6 protocols using protein l

1

Antigen Strip Preparation for Immunoblots

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antigen strips for Bbsl and RFB immunoblots were prepared as previously described [1 (link),2 (link)]. In brief, purified proteins and control proteins were diluted (7–19 ng protein/line) and sprayed in straight lines on nitrocellulose sheets (Amersham Protran, GE Healthcare Life Science) using a BioDot liquid dispenser (BioDot, Irvine, CA, USA). Protein L (Sigma, St. Louis, MO, USA) and mixed human immunoglobulin M (IgM) and IgG (Sigma, St. Louis, MO, USA) were used as control proteins for detecting the addition of human serum and for detecting the addition of alkaline phosphatase conjugated anti-human antibodies. The sheets were then blocked with 5% non-fat dry milk and sliced into 3-mm-wide strips.
+ Open protocol
+ Expand
2

Calibration and control antibodies in TBRF and LD IBs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Alkaline phosphatase-conjugated rabbit antibody to the 39/93 kDa LDB antigens (Strategic Biosciences, Stow, MA, USA) diluted in human serum was used as a calibration control in both TBRF and LD IBs and bands with lower intensity than the calibration control were considered to be negative [34 (link)]. The two proteins used as controls in both IBs were a mixture of human IgM and IgG (Sigma, St. Louis, MO, USA) for detecting the addition of alkaline phosphatase conjugated anti-human antibodies (C1), and Protein L (Sigma, St. Louis, MO, USA) for detecting the addition of human serum (C2), as previously described [34 (link)].
Immune rabbit sera for use as a marker control in TBRF IBs were prepared by immunizing individual rabbits separately with each of the recombinant antigens from the different RFB species used in TBRF IBs (Pacific Immunology, Ramona, CA, USA). The rabbit sera were then pooled and used at a dilution of 10−4 in a single control IB strip. Alkaline phosphatase-labelled goat anti-rabbit whole IgG (KPL, Gaithersburg, MD, USA) was used as the secondary antibody.
+ Open protocol
+ Expand
3

Antigen Strip Preparation for IB Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antigen strips were prepared essentially as described for our previously developed IB assays for borreliosis [9 (link), 10 (link)]. Purified antigens diluted to yield approximately 7–19 ng of protein as a line in each 3 mm strip of membrane were sprayed in straight lines onto nitrocellulose membrane (Amersham Protran, GE Healthcare Life Science, Chicago, IL) using a BioDot liquid dispenser (BioDot, Irvine, CA). Human IgG and IgM (Sigma, St. Louis, MO) were applied as controls C1 and C4 respectively in all IB strips for establishing the specificity of antibody class detection and for confirming the addition of alkaline phosphatase conjugated anti-human antibodies. Protein L (Sigma, St. Louis, MO) was used as control C2 for detecting the addition of human serum. A calibration standard C3 was applied on the test strip for use in all IB assays. The membranes were then blocked with 5% dried skim milk and sliced into 3 mm wide strips. The membrane strips containing antigens could be stored for at least 6 months at 2-8 °C before their use for IB assays.
+ Open protocol
+ Expand
4

Surface Plasmon Resonance Analysis of hCD134-Fc Binding

Check if the same lab product or an alternative is used in the 5 most similar protocols
The surface plasmon resonance experiments were conducted with BiacoreT200 instruments according to the manufacturer's protocol (GE Healthcare). In brief, each of recombinant Protein A (Sigma, St. Louis, MO) or a 1:1 mixture of Protein A and Protein L (Sigma) were immobilized on a CM5 censor chip by an amine coupling method according to the provided protocol (GE Healthcare). The hCD134-Fc was captured via Protein A, and the Mabs were captured via Protein A/L as ligands. The soluble tetramer at a series of concentrations was injected as the analyte, and the response curves were recorded. The signals from a ligand-blank path was subtracted as a baseline. The sensorgrams were analyzed by the software program BIAevaluation (GE Healthcare).
+ Open protocol
+ Expand
5

Inhibitor-based Cellular Signaling Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Reagents, including puromycin and blasticidin, were acquired from InvivoGen (San Diego, CA, USA). Polybrene was obtained from Santa Cruz Biotechnology (Dallas, TX). The inhibitors, PD98059 was obtained from Santa Cruz Biotechnology and dissolved in DMSO (Sigma-Aldrich, St. Louis, MO, USA). Dapansutrile (OLT117) was obtained from Selleck Chemicals (Houston, TX, USA), and canakinumab (Ilaris) was obtained from R&D Systems (Minneapolis, MN, USA). RhEGF was purchased from R&D Systems. Protein L was obtained from Sigma-Aldrich. HLA-G blocking/neutralizing antibody (clone 87G) was obtained from BioLegend (San Diego, CA, USA).
+ Open protocol
+ Expand
6

Immunoprecipitation and Mass Spectrometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Direct immunoprecipitation studies were performed with MAb 9E1 and control mouse IgG (Sigma, I5381) using protein L (P3351, Sigma, UK)/protein G agarose (Pierce, 22852). Purification, dialysis and concentration of MAb 9E1, pre-clearing of lysates, immunoprecipitation of the antibody-antigen complex, washing, elution and SDS–PAGE of 9E1 and mouse IgG immunoprecipitates were carried out as previously described (Larkin et al, 2005 (link); O'Sullivan et al, 2014 (link)). Following gel electrophoresis, gels were stained with Brilliant Blue Colloidal Coomassie to visualise precipitated proteins. For validation of mass spectrometry identifications, gels were probed with relevant antibodies for western blotting (WB) analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!